Market Survey on Arthropod-borne Viral Infections Testing Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Arthropod-borne Viral Infections Testing Market including ELISA-based Tests for Arthropod-borne Viral Infections Testing, RT-PCR-based Tests for Arthropod-borne Viral Infections Testing, and Immunochromatography Rapid Diagnosis for Arthropod-borne Viral Infections Testing Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Arthropod-borne Viral Infections Testing Market Outlook (2022-2029)
[206 Pages Report] Rising at a CAGR of 5.6% from 2022 to 2029, arthropod-borne viral infections testing demand is estimated to attain a valuation of US$ 1.3 Bn by end of the forecast period. The global Arthropod-Borne Viral Infections Testing Market is worth US$ 1.9 Bn in 2022.
Arboviral diseases are infections caused by virus spread among humans through the bites of arthropods. Common arthropods through which diseases are spread are mosquitoes and ticks. Arthropod-borne viral infections testing accounts for 4.4% of the global infectious disease diagnostics market, which stood at US$ 28 Bn in 2021.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
5.64%
H1, 2022 Projected
5.63%
H1, 2022 Outlook
3.83%
BPS Change - H1, 2022 (O) – H1, 2022 (P)
(-) 180 ↓
BPS Change – H1, 2022 (O) – H1, 2021
(-) 181 ↓
The variation between the BPS values observed within the arthropod-borne viral infections testing market in H1, 2022 - outlook over H1, 2022 projected reflects a decline by 180 BPS units. Additionally, a value BPS decline in H1-2022 over H1-2021 by 181 Basis Point Share (BPS) is demonstrated by the market.
The market observes a decline in the BPS values owed to the poor accessibility of detection methods in low-income economies with a large disease burden. As a result, high costs of healthcare facilities along with a lack of awareness about infectious diseases are expected to restrain the market's growth.
The market is subjected to several macro economical and industry variables, which include disease epidemiology, biologics licensing, product patenting and distribution licensing. Factors such as climate change, urbanization, and global trade can expand the geographic distribution of vectors and associated arboviruses, thus increasing the potential disease burden in susceptible hosts. This factor can present an opportunity for a positive growth outlook for the market
Demand Analysis of Arthropod-borne Viral Infections Testing (2014 to 2021) Vs Market Metrics (2022 to 2029)
Healthcare has become an area of prime concern across the world and this is due to the rising diseases and infections across the world. There has been a substantial rise in arboviral diseases over the past few years and this has influenced demand for arthropod-borne viral infections testing.
Arthropod-borne viral infections testing demand rose at a CAGR of 4.9% from 2014 to 2021 and ended up with a market worth of US$ 1.2 Bn in 2021.
Most common arthropod-borne viral infection in the world according to WHO (World Health Organization) is dengue, with the potential risk to infect more than 30% of the world’s population.
Rising focus on public healthcare, increasing travel and trade activities on a global scale, changing lifestyle trends, environmental and climatic changes, rapid urbanization across the world, etc. are some major factors that influence arthropod-borne viral infections testing market potential on a global scale.
The market for arthropod-borne viral infections testing is anticipated to rise at a CAGR of 5.6% over the forecast period of 2022 to 2029.
Which Factors Favor Arthropod-borne Viral Infections Testing Market Potential?
“Re-emergence of Arthropod-borne Viral Infections to Drive Demand”
Arthropod-borne infections have proven to be responsible for widespread epidemics across the world. Some of the notable arboviral epidemics are of dengue and Zika virus which led to further complications in the population infected.
These epidemics have been dealt with to a certain extent but have proven their re-emergence in recent times which is a major factor that drives demand for arthropod-borne viral infections testing on a global level. The unpredictable nature of these infections promotes arthropod-borne viral infections testing providers to develop better diagnostic solutions to detect and avoid a community spread of these infections.
“Increasing Government Initiatives to Limit Risk of Arboviral Infections”
Governments across the world are working in sync with health organizations to mitigate the risk of arthropod-borne viral infections. As a matter of public safety, the focus on these diseases is increasing in the past few years with severe outbreaks being recorded across the world. The emergence of coronavirus in 2020 has further bolstered the importance of government inclusion in matters of public health.
For instance, a pilot program funded by Global Emerging Infectious Surveillance (GEIS) a division of Armed Forces Health Surveillance Branch of the U.S. is set to launch in spring of 2022 to identify emerging infectious diseases and mitigate risk. This is expected to be attained by a global laboratory network that is designed to enhance global health security.
Which Regions Should Arthropod-borne Viral Infections Testing Providers Focus On?
“MEA and Latin America to Provide Major Opportunities for Market Players”
This FMI industry analysis provides metrics for the arthropod-borne viral infections testing market across regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).
The market for arthropod-borne viral infections testing in Latin America is anticipated to see high demand over the forecast period as it accounts for a notable number of infections across the world.
Developing healthcare infrastructure and rising awareness about arthropod-borne infections is anticipated to influence arthropod-borne viral infections testing demand in this region.
Demand for arthropod-borne viral infections testing in North America is expected to be low as the incidence of arboviral infections and diseases in this region is low. Advanced healthcare infrastructure and proper preventive care reduce the chances of infection in this region.
East Asia and South Asia are expected to see high demand for arthropod-borne viral infections testing over the forecast period. Implementation of stringent regulations to curb the spread of infectious diseases in this region is anticipated to drive market potential in these regions.
Densely populated countries like India and China are expected to emerge as highly lucrative markets for arthropod-borne viral infections testing vendors.
Rising instances of arboviral infections and epidemics in the MEA region are expected to majorly drive demand for arthropod-borne viral infections testing in this region. This region is expected to be one of the most important markets on a global level owing to the re-emergence of multiple infections like Zika virus and others.
Underdeveloped healthcare infrastructure is a major restraining factor for arthropod-borne viral infections testing market in the MEA region.
Find your sweet spots for generating winning opportunities in this market.
Country-wise Analysis
Why is the U.K. a Lucrative Market for Arthropod-borne Viral Infections Testing Providers?
“Increasing Threat of Arboviral Infections Augmenting Market Expansion”
Instances of arthropod-borne viral infections have been increasing in the U.K. in recent times and this is anticipated to drive arthropod-borne viral infections testing demand in the nation. Lyme disease has become a prominent issue in the U.K. over recent years and other arthropod-borne diseases have also seen an increase in incidence.
Increasing global travel and trade are expected to fuel the adoption of arthropod-borne viral infections testing in the U.K.
What is the Outlook for Arthropod-borne Viral Infections Testing in Brazil?
“Developing Healthcare Infrastructure to Provide Lucrative Market Opportunities”
Brazil is anticipated to be a highly rewarding market for arthropod-borne viral infections testing vendors due to high incidence of multiple arthropod-borne viral infections like Zika virus and dengue. Brazil is a developing economy and has an emerging healthcare infrastructure that has a lot of untapped potential that arthropod-borne viral infections testing providers can unlock if they enter this market.
Category-wise Analysis
Which Test Type is Expected to Perform the Best?
“High Preference for ELISA-based Test Kits to Drive Sales through 2029”
Enzyme-linked immunosorbent assay (ELISA)-based tests have been immensely popular in the arthropod-borne viral infections testing marketplace over the past few years and currently account for a dominant market share of 52% in the global landscape.
Increasing preference for use of ELISA-based test kits by patients, healthcare professionals, researchers, etc. is expected to propel its popularity further.
In 2022, reverse-transcription polymerase chain reaction (RT-PCR) kits hold a market share of 33.5% in the global arthropod-borne viral infections testing industry. The COVID-19 pandemic boosted demand for RT-PCR test kits and this trend is expected to be prevalent over the forecast period as well.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
COVID-19 Crisis Survey
The COVID-19 pandemic invigorated demand for arthropod-borne viral infections testing and revolutionized our view on infectious diseases and infections. Increasing uncertainties in these diseases and their re-emergence are anticipated to play a major role in the coming years.
Sales of arthropod-borne viral infections testing kits dropped in 2020 as lockdown mandates were put in place and supply and logistic chains were disrupted. The market is expected to make a steady recovery in the post-pandemic era as restrictions are lifted across the world.
Competitive Landscape
Arthropod-borne viral infections testing providers are investing in the research and development of rapid test kits that are effective in diagnosing infections in a short period of time with minimal error.
In November 2021, Achico, a healthcare technology firm headquartered in Switzerland, announced the development of dengue fever diagnostic kits. This new testing kit would be based on the company’s DNA aptamer technology platform that has proven its efficiency in COVID-19 diagnosis.
Arthropod-borne Viral Infections Testing Industry Report Scope
Attribute
Details
Forecast Period
2022-2029
Historical Data Available for
2014-2021
Market Analysis
US$ Mn for Value
Key Regions Covered
North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa (MEA)
Key Countries Covered
United States
Canada
Brazil
Mexico
Germany
U.K.
France
Spain
Italy
China
Japan
South Korea
India
Indonesia
Malaysia
Singapore
Australia
New Zealand
Turkey
South Africa
and GCC Countries
Key Market Segments Covered
Test Type
End User
Region
Key Companies Profiled
Thermo Fisher Scientific Inc.
Roche Molecular Systems Inc.
bioMérieux SA
InBios International Inc.
NovaTec Immundiagnostica GmbH
Euroimmun AG (Sub. PerkinElmer)
Quest Diagnostics
Certest Biotec S.L.
Response Biomedical Corp.
Chembio Diagnostic Systems Inc.
Abbott Laboratories
Pricing
Available upon Request
Key Segments of Arthropod-borne Viral Infections Testing Industry Survey
Arthropod-borne Viral Infections Testing Market by Test Type:
ELISA-based Tests for Arthropod-borne Viral Infections Testing
RT-PCR-based Tests for Arthropod-borne Viral Infections Testing
Immunochromatography Rapid Diagnosis for Arthropod-borne Viral Infections Testing
Arthropod-borne Viral Infections Testing Market by End User:
Arthropod-borne Viral Infections in Testing Hospitals
Arthropod-borne Viral Infections in Public Health Laboratories
Arthropod-borne Viral Infections in Diagnostic Centres
Others
Arthropod-borne Viral Infections Testing Market by Region:
North America Arthropod-borne Viral Infections Testing Market
Latin America Arthropod-borne Viral Infections Testing Market
Europe Arthropod-borne Viral Infections Testing Market
East Asia Arthropod-borne Viral Infections Testing Market
South Asia & Pacific Arthropod-borne Viral Infections Testing Market
Middle East & Africa (MEA) Arthropod-borne Viral Infections Testing Market
Frequently Asked Questions
What is the arthropod-borne viral infections testing market worth?
The global arthropod-borne viral infections testing market holds a valuation of US$ 1.3 Bn in 2022.
What market share is held by ELISA-based tests in 2022?
ELISA-based tests account for 52% of the global arthropod-borne viral infections testing market share.
At what CAGR is the arthropod-borne viral infections testing industry anticipated to progress going forward?
Demand for arthropod-borne viral infections testing is predicted to evolve at a CAGR of 5.6% from 2022 to 2029.
What market statistics are forecasted for 2029?
Sales of arthropod-borne viral infections testing kits are projected to reach US$ 1.9 Bn by 2029.
Which key players are profiled in this arthropod-borne viral infections testing industry survey?
Leading arthropod-borne viral infections testing companies are Roche Molecular Systems Inc., bioMérieux SA, InBios International Inc., NovaTec Immundiagnostica GmbH, Euroimmun AG (Sub. PerkinElmer), Quest Diagnostics, Certest Biotec S.L., Response Biomedical Corp., Chembio Diagnostic Systems Inc., and Abbott Laboratories.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
3.3. Macro-Economic Factors
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Disease Epidemiology, By Key countries
4.3. Strategic Promotional Strategies
4.4. Regulatory Scenario
4.5. Opportunity Analysis
5. Global Arthropod-borne Viral Infections Testing Market Demand Analysis 2014-2021 and Forecast, 2022-2029
5.1. Historical Market Volume (Mn Units) Analysis, 2014-2021
5.2. Current and Future Market Volume (Mn Units) Projections, 2022-2029
5.3. Y-o-Y Growth Trend Analysis
6. Global Arthropod-borne Viral Infections Testing Market - Pricing Analysis
6.1. Regional Pricing Analysis By Test Type
6.2. Pricing Break-up
6.2.1. Manufacturer Level Pricing
6.2.2. Distributor Level Pricing
6.3. Global Average Pricing Analysis Benchmark
7. Global Arthropod-borne Viral Infections Testing Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029
7.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Global Internet Penetration Outlook
8.1.3. Global Media and Entertainment Industry Outlook
8.2. Forecast Factors - Relevance & Impact
8.2.1. Top Companies Historical Growth
8.2.2. Global Healthcare Industry Outlook
8.2.3. Global GDP Growth Outlook
8.2.4. Research and Developmental Activities
8.2.5. Global Diagnostic Industry Outlook
8.3. Value Chain
8.4. Market Dynamics
8.4.1. Drivers
8.4.2. Restraints
8.4.3. Opportunity Analysis
9. Global Arthropod-borne Viral Infections Testing Market Analysis 2014-2021 and Forecast 2022-2029, by Test Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Test Type, 2014-2021
9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Test Type, 2021 - 2021
9.3.1. ELISA-based Tests
9.3.2. RT-PCR based Tests
9.3.3. Immunochromatography Rapid Diagnosis
9.4. Market Attractiveness Analysis By Test Type
10.Global Arthropod-borne Viral Infections Testing Market Analysis 2014-2021 and Forecast 2022-2029, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume Analysis By End User, 2014-2021
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By End User, 2021 - 2021
10.3.1. Hospitals
10.3.2. Public Health Laboratory
10.3.3. Diagnostic Centers
10.3.4. Others
10.4. Market Attractiveness Analysis By End User
11.Global Arthropod-borne Viral Infections Testing Market Analysis 2014-2021 and Forecast 2022-2029, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2014-2021
11.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2021 - 2021
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Middle East and Africa (MEA)
11.3.5. East Asia
11.3.6. South Asia
11.3.7. Oceania
11.4. Market Attractiveness Analysis By Region
12. North America Arthropod-borne Viral Infections Testing Market Analysis 2014-2021 and Forecast 2022-2029
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014-2021
12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022-2029
12.4.1.By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.2. By Test Type
12.4.3. By End User
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Test Type
12.5.3. By End User
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. Latin America Arthropod-borne Viral Infections Testing Market Analysis 2014-2021 and Forecast 2022-2029
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014-2021
13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022-2029
13.4.1.By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Test Type
13.4.3. By End User
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Test Type
13.5.3. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14.Europe Arthropod-borne Viral Infections Testing Market Analysis 2014-2021 and Forecast 2022-2029
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014-2021
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022-2029
14.4.1.By Country
14.4.1.1. Germany
14.4.1.2. Italy
14.4.1.3. France
14.4.1.4. U.K.
14.4.1.5. Spain
14.4.1.6. BENELUX
14.4.1.7. Russia
14.4.1.8. Rest of Europe
14.4.2. By Test Type
14.4.3. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Test Type
14.5.3. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15.South Asia Arthropod-borne Viral Infections Testing Market Analysis 2014-2021 and Forecast 2022-2029
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014-2021
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022-2029
15.4.1.By Country
15.4.1.1. India
15.4.1.2. Thailand
15.4.1.3. Indonesia
15.4.1.4. Malaysia
15.4.1.5. Rest of South Asia
15.4.2. By Test Type
15.4.3. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Test Type
15.5.3. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16.East Asia Arthropod-borne Viral Infections Testing Market Analysis 2014-2021 and Forecast 2022-2029
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014-2021
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022-2029
16.4.1.By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.2. By Test Type
16.4.3. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Test Type
16.5.3. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17.Oceania Arthropod-borne Viral Infections Testing Market Analysis 2014-2021 and Forecast 2022-2029
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014-2021
17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022-2029
17.4.1.By Country
17.4.1.1. Australia
17.4.1.2. New Zealand
17.4.2. By Test Type
17.4.3. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Test Type
17.5.3. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18.Middle East and Africa Arthropod-borne Viral Infections Testing Market Analysis 2014-2021 and Forecast 2022-2029
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014-2021
18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022-2029
18.4.1. By Country
18.4.1.1. GCC Countries
18.4.1.2. Turkey
18.4.1.3. Northern Africa
18.4.1.4. South Africa
18.4.1.5. Rest of Middle East and Africa
18.4.2. By Test Type
18.4.3. By End User
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Test Type
18.5.3. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Key and Emerging Countries Arthropod-borne Viral Infections Testing Market Analysis 2014-2021 and Forecast 2022-2029
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Arthropod-borne Viral Infections Testing Market Analysis
19.2.1. By Test Type
19.2.2. By End User
19.3. Canada Arthropod-borne Viral Infections Testing Market Analysis
19.3.1. By Test Type
19.3.2. By End User
19.4. Mexico Arthropod-borne Viral Infections Testing Market Analysis
19.4.1. By Test Type
19.4.2. By End User
19.5. Brazil Arthropod-borne Viral Infections Testing Market Analysis
19.5.1. By Test Type
19.5.2. By End User
19.6. U.K. Arthropod-borne Viral Infections Testing Market Analysis
19.6.1. By Test Type
19.6.2. By End User
19.7. Germany Arthropod-borne Viral Infections Testing Market Analysis
19.7.1. By Test Type
19.7.2. By End User
19.8. France Arthropod-borne Viral Infections Testing Market Analysis
19.8.1. By Test Type
19.8.2. By End User
19.9. Italy Arthropod-borne Viral Infections Testing Market Analysis
19.9.1. By Test Type
19.9.2. By End User
19.10. Spain Arthropod-borne Viral Infections Testing Market Analysis
19.10.1. By Test Type
19.10.2. By End User
19.11. BENELUX Arthropod-borne Viral Infections Testing Market Analysis
19.11.1. By Test Type
19.11.2. By End User
19.12. Russia Arthropod-borne Viral Infections Testing Market Analysis
19.12.1. By Test Type
19.12.2. By End User
19.13. China Arthropod-borne Viral Infections Testing Market Analysis
19.13.1. By Test Type
19.13.2. By End User
19.14. Japan Arthropod-borne Viral Infections Testing Market Analysis
19.14.1. By Test Type
19.14.2. By End User
19.15. South Korea Arthropod-borne Viral Infections Testing Market Analysis
19.15.1. By Test Type
19.15.2. By End User
19.16. India Arthropod-borne Viral Infections Testing Market Analysis
19.16.1. By Test Type
19.16.2. By End User
19.17. ASEAN Arthropod-borne Viral Infections Testing Market Analysis
19.17.1. By Test Type
19.17.2. By End User
19.18. Australia Arthropod-borne Viral Infections Testing Market Analysis
19.18.1. By Test Type
19.18.2. By End User
19.19. New Zealand Arthropod-borne Viral Infections Testing Market Analysis
19.19.1. By Test Type
19.19.2. By End User
19.20. GCC Countries Arthropod-borne Viral Infections Testing Market Analysis
19.20.1. By Test Type
19.20.2. By End User
19.21. Turkey Arthropod-borne Viral Infections Testing Market Analysis
19.21.1. By Test Type
19.21.2. By End User
19.22. South Africa Arthropod-borne Viral Infections Testing Market Analysis
19.22.1. By Test Type
19.22.2. By End User
20.Market Structure Analysis
20.1. Market Analysis by Tier of Companies (Arbovirus Testing)
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Product foot print by Players
20.4.3. Channel Foot Print by Players
21.Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Thermo Fisher Scientific, Inc.
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Marketing Strategy
21.3.1.5.2. Product Strategy
21.3.1.5.3. Channel Strategy
21.3.2. Roche Molecular Systems Inc.
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Marketing Strategy
21.3.2.5.2. Product Strategy
21.3.2.5.3. Channel Strategy
21.3.3. bioMérieux SA
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Marketing Strategy
21.3.3.5.2. Product Strategy
21.3.3.5.3. Channel Strategy
21.3.4. Abbott Laboratories
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Marketing Strategy
21.3.4.5.2. Product Strategy
21.3.4.5.3. Channel Strategy
21.3.5. InBios International, Inc.
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Marketing Strategy
21.3.5.5.2. Product Strategy
21.3.5.5.3. Channel Strategy
21.3.6. NovaTec Immundiagnostica GmbH
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Marketing Strategy
21.3.6.5.2. Product Strategy
21.3.6.5.3. Channel Strategy
21.3.7. Euroimmun AG (Sub. PerkinElmer)
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Marketing Strategy
21.3.7.5.2. Product Strategy
21.3.7.5.3. Channel Strategy
21.3.8. Quest Diagnostics
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
21.3.8.4. Sales Footprint
21.3.8.5. Strategy Overview
21.3.8.5.1. Marketing Strategy
21.3.8.5.2. Product Strategy
21.3.8.5.3. Channel Strategy
21.3.9. Certest Biotec S.L.
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
21.3.9.4. Sales Footprint
21.3.9.5. Strategy Overview
21.3.9.5.1. Marketing Strategy
21.3.9.5.2. Product Strategy
21.3.9.5.3. Channel Strategy
21.3.10. Response Biomedical Corp.
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
21.3.10.4. Sales Footprint
21.3.10.5. Strategy Overview
21.3.10.5.1. Marketing Strategy
21.3.10.5.2. Product Strategy
21.3.10.5.3. Channel Strategy
21.3.11. Chembio Diagnostic Systems, Inc.
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
21.3.11.4. Sales Footprint
21.3.11.5. Strategy Overview
21.3.11.5.1. Marketing Strategy
21.3.11.5.2. Product Strategy
21.3.11.5.3. Channel Strategy
22.Assumptions and Acronyms Used23. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1 : Global Arthropod-borne Viral Infections Testing Market Size (US$ Mn) 2014-2021 and Forecast 2022-2029 By Test Type,
Table 2 : Global Arthropod-borne Viral Infections Testing Market Size (US$ Mn) 2014-2021 and Forecast 2022-2029 By End User,
Table 3 : Global Arthropod-borne Viral Infections Testing Market Size (US$ Mn) 2014-2021 and Forecast 2022-2029 By Region
Table 4 : North America Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 5 : North America Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Test Type
Table 6 : North America Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 7 : Latin America Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 8 : Latin America Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Test Type
Table 9: Latin America Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 10 : Europe Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 11 : Europe Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Test Type
Table 12 : Europe Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 13 : South Asia Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 14 : South Asia Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Test Type
Table 15 : South Asia Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 16 : East Asia Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 17 : East Asia Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Test Type
Table 18 : East Asia Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 19 : Oceania Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 20 : Oceania Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Test Type
Table 21 : Oceania Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 22 : Middle East & Africa Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 23 : Middle East & Africa Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Test Type
Table 24 : Middle East & Africa Arthropod-borne Viral Infections Testing Market Size Analysis (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Arthropod-Borne Viral Infections Testing Market Value Share, By Test Type (2021)
Figure 02: Global Arthropod-Borne Viral Infections Testing Market Value Share, by End User(2021)
Figure 03: Global Arthropod-Borne Viral Infections Testing Market Value Share, by Region (2021)
Figure 04: Global Arthropod-Borne Viral Infections Testing Market Value Analysis (US$ Mn), 2014-2021
Figure 05: Global Arthropod-Borne Viral Infections Testing Market Value Analysis (US$ Mn), 2022-2029
Figure 06: Global Arthropod-Borne Viral Infections Testing Market Absolute $ Opportunity, 2014-2021
Figure 07: Global Arthropod-Borne Viral Infections Testing Market Absolute $ Opportunity, 2022-2029
Figure 08 : Global Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis By Test Type, 2022-2029
Figure 09 : Global Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis By End User, 2022-2029
Figure 10 : Global Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis By Region, 2022-2029
Figure 11 : North America Arthropod-Borne Viral Infections Testing Market Split By End User (2019E)
Figure 12 : North America Arthropod-Borne Viral Infections Testing Market Split By Test Type (2019E)
Figure 13 : North America Arthropod-Borne Viral Infections Testing Market Split By Region (2019E)
Figure 14 : North America Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) Analysis, 2014-2021
Figure 15 : North America Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2029
Figure 16 : North America Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Country
Figure 17 : North America Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Test Type
Figure 18 : North America Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By End User
Figure 19 : Latin America Arthropod-Borne Viral Infections Testing Market Split By Test Type (2019E)
Figure 20 : Latin America Arthropod-Borne Viral Infections Testing Market Split By End User (2019E)
Figure 21 : Latin America Arthropod-Borne Viral Infections Testing Market Split By Region (2019E)
Figure 22 : Latin America Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) Analysis, 2014-2021
Figure 23 : Latin America Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2029
Figure 24 : Latin America Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Country
Figure 25 : Latin America Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Test Type
Figure 26 : Latin America Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By End User
Figure 27 : Europe Arthropod-Borne Viral Infections Testing Market Split By End User (2019E)
Figure 28 : Europe Arthropod-Borne Viral Infections Testing Market Split By Test Type (2019E)
Figure 29 : Europe Arthropod-Borne Viral Infections Testing Market Split By Region (2019E)
Figure 30 : Europe Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) Analysis, 2014-2021
Figure 31 : Europe Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2029
Figure 32 : Europe Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Country
Figure 33 : Europe Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Test Type
Figure 34 : Europe Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By End User
Figure 35 : South Asia Arthropod-Borne Viral Infections Testing Market Split By End User (2019E)
Figure 36 : South Asia Arthropod-Borne Viral Infections Testing Market Split By Test Type (2019E)
Figure 37 : South Asia Arthropod-Borne Viral Infections Testing Market Split By Region (2019E)
Figure 38 : South Asia Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) Analysis, 2014-2021
Figure 39 : South Asia Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2029
Figure 40 : South Asia Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Country
Figure 41 : South Asia Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Test Type
Figure 42 : South Asia Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By End User
Figure 43 : East Asia Arthropod-Borne Viral Infections Testing Market Split By End User (2019E)
Figure 44 : East Asia Arthropod-Borne Viral Infections Testing Market Split By Test Type (2019E)
Figure 45 : East Asia Arthropod-Borne Viral Infections Testing Market Split By Region (2019E)
Figure 46 : East Asia Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) Analysis, 2014-2021
Figure 47 : East Asia Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2029
Figure 48 : East Asia Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Country
Figure 49 : East Asia Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Test Type
Figure 50 : East Asia Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By End User
Figure 51 : Oceania Arthropod-Borne Viral Infections Testing Market Split By End User (2019E)
Figure 52 : Oceania Arthropod-Borne Viral Infections Testing Market Split By Test Type (2019E)
Figure 53 : Oceania Arthropod-Borne Viral Infections Testing Market Split By Region (2019E)
Figure 54 : Oceania Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) Analysis, 2014-2021
Figure 55 : Oceania Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2029
Figure 56 : Oceania Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Country
Figure 57 : East Asia Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Test Type
Figure 58 : Oceania Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By End User
Figure 59 : Middle East & Africa Arthropod-Borne Viral Infections Testing Market Split By End User (2019E)
Figure 60 : Middle East & Africa Arthropod-Borne Viral Infections Testing Market Split By Test Type (2019E)
Figure 61 : Middle East & Africa Arthropod-Borne Viral Infections Testing Market Split By Region (2019E)
Figure 62 : Middle East & Africa Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) Analysis, 2014-2021
Figure 63 : Middle East & Africa Arthropod-Borne Viral Infections Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2029
Figure 64 : Middle East & Africa Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Country
Figure 65 : East Asia Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By Test Type
Figure 66 : Middle East & Africa Arthropod-Borne Viral Infections Testing Market Attractiveness Analysis, By End User
Figure 67: U.S Market Value Proportion Analysis, 2021
Figure 68: U.S. Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 69 : U.S. Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 70: Global Vs. U.S Growth Comparison, 2022-2029
Figure 71: Canada Market Value Proportion Analysis, 2021
Figure 72: Canada Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 73: Canada Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 74: Global Vs. Canada Growth Comparison, 2022-2029
Figure 75: Brazil Market Value Proportion Analysis, 2021
Figure 76: Brazil Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 77: Brazil Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 78: Global Vs. Brazil Growth Comparison, 2022-2029
Figure 79: Mexico Market Value Proportion Analysis, 2021
Figure 80: Mexico Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 81: Mexico Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 82: Global Vs. Mexico Growth Comparison, 2022-2029
Figure 83: Argentina Market Value Proportion Analysis, 2021
Figure 84: Argentina Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 85: Argentina Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 86: Global Vs. Argentina Growth Comparison, 2022-2029
Figure 87: Germany Market Value Proportion Analysis, 2021
Figure 88: Germany Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 89: Germany Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 90: Global Vs. Germany Growth Comparison, 2022-2029
Figure 91: France Market Value Proportion Analysis, 2021
Figure 92: France Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 93: Figure: France Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 94: Global Vs. France Growth Comparison, 2022-2029
Figure 95: Spain Market Value Proportion Analysis, 2021
Figure 96: Spain Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 97: Spain Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 98: Global Vs. Spain Growth Comparison, 2022-2029
Figure 99: Italy Market Value Proportion Analysis, 2021
Figure 100: Italy Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 101: Italy Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 102: Global Vs. Italy Growth Comparison, 2022-2029
Figure 104: Russia Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 105: Russia Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 106: Global Vs. Russia Growth Comparison, 2022-2029
Figure 107: India Market Value Proportion Analysis, 2021
Figure 108: India Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 110: Global Vs. India Growth Comparison, 2022-2029
Figure 111: Thailand Market Value Proportion Analysis, 2021
Figure 112: Thailand Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 113: Thailand Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 114: Global Vs. Thailand Growth Comparison, 2022-2029
Figure 115: Malaysia Market Value Proportion Analysis, 2021
Figure 116: Malaysia Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 117: Malaysia Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 118: Global Vs. Malaysia Growth Comparison, 2022-2029
Figure 119: Indonesia Market Value Proportion Analysis, 2021
Figure 120: Indonesia Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 121: Indonesia Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 122: Global Vs. Indonesia Growth Comparison, 2022-2029
Figure 123: China Market Value Proportion Analysis, 2021
Figure 124: China Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 125: China Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 126: Global Vs. China Growth Comparison, 2022-2029
Figure 127: Japan Market Value Proportion Analysis, 2021
Figure 128: Japan Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 129: Japan Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 130: Global Vs. Japan Growth Comparison, 2022-2029
Figure 132: South Korea Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 133: South Korea Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 134: Global Vs. South Korea Growth Comparison, 2022-2029
Figure 135: Australia Market Value Proportion Analysis, 2021
Figure 136: Australia Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 137: Australia Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 138: Global Vs. Australia Growth Comparison, 2022-2029
Figure 139: South Africa Market Value Proportion Analysis, 2021
Figure 140: South Africa Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 141: South Africa Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 142: Global Vs. South Africa Growth Comparison, 2022-2029
Figure 143: Turkey Market Value Proportion Analysis, 2021
Figure 144: Turkey Arthropod-Borne Viral Infections Testing Market Analysis by Test Type, 2022 & 2029
Figure 145: Turkey Arthropod-Borne Viral Infections Testing Market Analysis by End User, 2022 & 2029
Figure 146: Global Vs. Turkey Growth Comparison, 2022-2029
